Top 30 VC Firms for Healthcare & Biotech Startups (2025)
The Best VC Firms for Healthcare & Biotech in 2025
Healthcare and biotech venture capital is experiencing a renaissance. In 2025, over $60 billion flows into health-related startups annually, driven by advances in AI-powered diagnostics, gene therapy, digital health platforms, and precision medicine. This guide profiles the top 30 VC firms actively investing in this transformative sector.
From early-stage therapeutics to growth-stage health IT, each firm on this list has a proven track record of backing successful healthcare companies.
Healthcare & Biotech VC: 2025 Numbers
Tier 1: Healthcare & Biotech Specialists
These firms invest exclusively in healthcare and life sciences. They bring deep scientific expertise, regulatory knowledge, and clinical development networks.
ARCH Venture Partners
Seed – Series B | $1M – $50M
One of the most successful early-stage biotech investors in the world. Portfolio includes Illumina, Alnylam Pharmaceuticals, Moderna (early investor), and Unity Biotechnology. Known for company creation from academic research.
OrbiMed
Series A – Growth | $5M – $200M
The largest healthcare-dedicated investment firm with $18B+ AUM. Invests across biopharma, medical devices, diagnostics, and health IT globally. Portfolio includes BioNTech, Minerva Neurosciences, and Phathom Pharmaceuticals.
Flagship Pioneering
Creation – Growth | $10M – $100M+
Unique "company creation" model that incubates breakthrough biotech companies. Created Moderna, Indigo Agriculture, Sana Biotechnology, and Generate Biomedicines. $34B+ in aggregate value created.
New Enterprise Associates (NEA)
Seed – Growth | $500K – $100M
One of the largest VCs with a major healthcare practice. Portfolio includes Genomic Health, Tempus, 10x Genomics, and Arcus Biosciences. Invests across digital health, biopharma, and devices.
Digital Health & Health IT Investors
These firms focus on the intersection of technology and healthcare — the fastest-growing sub-sector:
| Firm | Stage | Check Size | Focus Area | Notable Portfolio |
|---|---|---|---|---|
| GV (Google Ventures) | Seed–Series C | $1M–$50M | AI Health, Life Sci | Tempus, Verily, Flatiron Health |
| Andreessen Horowitz Bio | Seed–Series B | $2M–$75M | Bio + Tech Convergence | Freenome, Devoted Health, Insitro |
| Venrock | Seed–Series B | $1M–$30M | Biopharma, Health IT | Illumina, Athenahealth |
| Polaris Partners | Series A–B | $5M–$40M | MedTech, Diagnostics | Nuvira, Rapid Micro |
| F-Prime Capital | Seed–Series C | $1M–$50M | Health IT, Genomics | Flatiron Health, 23andMe |
| General Catalyst | Seed–Growth | $1M–$100M | Health System Innovation | Livongo, Ro, Hims |
Healthcare Sub-Sector Investment Map
Digital Health & Telehealth
Virtual care platforms, remote monitoring, mental health apps, and clinical workflow automation.
Therapeutics & Drug Discovery
AI-powered drug discovery, gene therapy, cell therapy, and novel biologics.
Medical Devices & Diagnostics
Wearables, point-of-care diagnostics, surgical robotics, and imaging technology.
Health IT & Infrastructure
EHR integration, revenue cycle management, clinical data platforms, and interoperability.
What Healthcare VCs Look For
Healthcare investing has unique evaluation criteria compared to general tech:
Key Evaluation Criteria
- • Clinical evidence: Published studies, FDA pathway clarity, and clinical validation data
- • Regulatory strategy: Clear pathway through FDA, CE marking, or relevant regulatory bodies
- • Reimbursement plan: How will payers (insurance, CMS) reimburse for your product?
- • Clinical champions: Key opinion leaders and clinicians who advocate for your solution
- • Domain expertise: Team with deep healthcare experience, not just tech backgrounds
- • IP position: Patents, trade secrets, and defensible technology moats
Raising Your Healthcare Series A
Healthcare Series A rounds tend to be larger than general tech due to regulatory costs and clinical trial requirements. Read our complete Series A fundraising playbook for stage-specific advice.
Healthcare Series A Benchmarks (2025)
Find Healthcare Investors
Access our verified database of healthcare and biotech-focused investors. Filter by sub-sector, stage, and check size to find the perfect match.
Browse Healthcare Investors →Frequently Asked Questions
How is healthcare VC fundraising different from tech?
Healthcare fundraising takes longer (12-24 months vs. 4-6 months), requires clinical and regulatory expertise, and often involves larger rounds due to clinical trial costs. Investors want to see domain expertise, regulatory pathway clarity, and clinical evidence.
Do I need FDA approval before raising?
No, but you need a clear regulatory strategy. Early-stage healthcare VCs expect you to understand the FDA pathway (510k, PMA, De Novo) and have a realistic timeline and budget for approval. Some invest specifically to fund the regulatory process.
What's the hottest area of healthcare VC in 2025?
AI-powered drug discovery, GLP-1 therapeutics, precision medicine, and clinical AI tools are seeing the most investor interest. Digital health remains strong but has matured — investors want proven unit economics. Learn how to raise your Series A.
Can a non-physician founder raise healthcare VC?
Yes, but you'll need strong clinical advisors or co-founders. The most successful health-tech companies combine tech expertise with clinical domain knowledge. Having an MD or PhD on the founding team helps significantly.
Where are the best healthcare investors based?
Boston/Cambridge is the biotech capital of the world. San Francisco leads in digital health and health IT. New York has strong health-tech ecosystems. Browse US healthcare investors in our database.
Tagged with
Investor Outreach Template Pack
Get our proven email templates, pitch frameworks, and investor research guides — used by 1,000+ founders.
- Cold email templates that get 40%+ open rates
- Follow-up sequence frameworks
- Investor research checklist
